Hematologic Response and Frequency of Side Effects in Chronic Myeloid Leukemia Patients Treated with Imatinib (GLIVEC): A South-East Asian Experience

被引：0
|
作者：
Aslam, Hafiz M.
Shumaila, Iqbal M.
Merchant, Ambreen A.
Muhammad, Mariam G.
Yasir, Javeria
Faizee, Faizan A.
Qadir, Madiha A.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5257
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Ocular side effects in chronic myeloid leukemia patients treated with imatinib
    Breccia, Massimo
    Gentilini, Fabiana
    Cannella, Laura
    Latagliata, Roberto
    Carmosino, Ida
    Frustaci, Annamaria
    Alimena, Giuliana
    LEUKEMIA RESEARCH, 2008, 32 (07) : 1022 - 1025
  • [2] Ocular side effects in chronic myeloid leukemia patients treated with Imatinib
    Breccia, M.
    Latagliata, R.
    Carmosino, I
    Cannella, L.
    Levi, A.
    Frustaci, A.
    Stefanizzi, C.
    Volpicelli, P.
    Alimena, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 183 - 183
  • [3] Molecular Monitoring of Response to Imatinib (Glivec) in Chronic Myeloid Leukemia Patients: Experience at a Tertiary Care Hospital in Saudi Arabia
    Khalil, Salem H.
    Abu-Amero, Khaled K.
    Al Mohareb, Fahad
    Chaudhri, Naeem A.
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2010, 14 (01) : 67 - 74
  • [4] PLASMATIC LEVELS, RESPONSE AND TOLERANCE TO IMATINIB AFTER THE CHANGE OF GLIVEC TO GENERIC IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE
    Wojnicz, A.
    Cornago Navascues, J.
    Vaitekovich, V.
    Mba, C.
    Sola Aparicio, E.
    Steegmann Olmedillas, J. L.
    HAEMATOLOGICA, 2018, 103 : 232 - 232
  • [5] Hematologic and cytogenetic response to imatinib mesylate in chronic myeloid leukemia
    Narayanan, G.
    Chacko, D. J.
    Koshy, A. A.
    Soman, L.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 82 : S18 - S18
  • [6] Response assessment of patients with chronic myeloid leukemia receiving imatinib mesylate (Glivec) therapy: experience from a single center in a developing country
    Medhi, Kunjahari
    Raina, Vinod
    Kumar, Lalit
    Sharma, Atul
    Bakhshi, Sameer
    Gupta, Ritu
    Kumar, Rajive
    LEUKEMIA & LYMPHOMA, 2010, 51 (10) : 1850 - 1854
  • [7] Activity of granulocyte myeloperoxidase in chronic myeloid leukemia patients treated with Glivec®
    Juricic, G
    Podolar, S
    Sucic, M
    CLINICA CHIMICA ACTA, 2005, 355 : S350 - S350
  • [8] Pregnancy in patients with chronic myeloid leukemia treated with imatinib
    Yilmaz, Mehmet
    Demirhan, Osman
    Kucukosmanoglu, Ercan
    Pehlivan, Mustafa
    Okan, Vahap
    Balat, Ozcan
    Pehlivan, Sacide
    LEUKEMIA & LYMPHOMA, 2007, 48 (12) : 2454 - 2456
  • [9] LONG TERM MOLECULAR RESPONSE IN IMATINIB TREATED CHRONIC MYELOID LEUKEMIA PATIENTS
    Jovanovic, V.
    Bogdanovic, D.
    Djordjevic, A.
    Dencic-Fekete, S.
    Gotic, D.
    HAEMATOLOGICA, 2012, 97 : 542 - 542
  • [10] Pharmacogenomic analysis of cytogenetic response in chronic myeloid leukemia patients treated with imatinib
    McLean, LA
    Gathmann, I
    Capdeville, R
    Polymeropoulos, MH
    Dressman, M
    CLINICAL CANCER RESEARCH, 2004, 10 (01) : 155 - 165
12345